Quality Botanical Ingredients, Inc. v. Triarco Industries, Inc. (In Re Quality Botanical Ingredients, Inc.)

249 B.R. 619, 2000 Bankr. LEXIS 646, 2000 WL 781403
CourtUnited States Bankruptcy Court, D. New Jersey
DecidedJune 16, 2000
Docket18-33461
StatusPublished
Cited by10 cases

This text of 249 B.R. 619 (Quality Botanical Ingredients, Inc. v. Triarco Industries, Inc. (In Re Quality Botanical Ingredients, Inc.)) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Quality Botanical Ingredients, Inc. v. Triarco Industries, Inc. (In Re Quality Botanical Ingredients, Inc.), 249 B.R. 619, 2000 Bankr. LEXIS 646, 2000 WL 781403 (N.J. 2000).

Opinion

MEMORANDUM OPINION

STEPHEN A. STRIPP, Bankruptcy Judge.

The plaintiff, which is the debtor-in-possession in this chapter 11 case, filed a complaint for damages and rescission of a settlement agreement entered as a consent order in a state court action. The complaint alleges defamation, breach of contract and tortious interference with prospective economic advantage, arising out of statements made by one of the defendants, who is the principal of the other defendant, at the meeting to form the committee of unsecured creditors. The defendants filed a motion for summary judgment, which plaintiff opposes. Plaintiff filed a motion to amend the complaint to add another party as plaintiff and to assert a preference avoidance action under 11 U.S.C. § 547, which defendants oppose. This is the court’s decision on the defendants’ motion for summary judgment and plaintiffs motion to amend the complaint. The court has jurisdiction pursuant to 28 U.S.C. §§ 1334(b), 151 and 157(a). This is a core proceeding under 28 U.S.C. § 157(b)(2)(A), (B), (C), (F) and (O). This shall constitute the court’s findings of fact and conclusions of law.

FINDINGS OF FACT

Rodger Rohde (“Rohde”) is president and principal of Triarco, Inc. (“Triarco,” or collectively “defendants”). Triarco is a supplier of bulk ingredients in the nutrition industry, and claims that the formulations of many of its products are proprietary, confidential and not generally known or available to the public. Triarco alleged that a predecessor of the debtor, Quality Botanical Ingredients, Inc. (“QBI” or “plaintiff’), known as Island Herbs, Inc. conspired with an employee of Triarco to gain access to Triarco’s trade secret information to unfairly compete with Triarco. These activities were the subject of a state court action filed by Triarco in 1993 in the Superior Court of New Jersey (“the state court action”). ¶ 9 of the amended complaint filed in that action states that defendants’ “[cjertificates of analysis and other documentation necessary in the industry for the sale of products ... were purloined by [Triarco’s' employee] ... and delivered to [QBI].” ¶ 11 of that amended complaint, which deals with allegations concerning certain patents belonging to Triarco, states that its employee “has sur *624 reptitiously gained possession of’ the patent materials “for his benefit and/or the benefit of [QBI].” Among other causes of action, the amended complaint alleged breach of contract, tortious interference with contract, unjust enrichment, fraud and conversion.

The state court action was settled with the entry of a consent order on January 15, 1998 (the “Consent Order”). The Consent Order provided that QBI was to pay to Triarco the sum of $1,200,000, under the terms of a promissory note dated December 11, 1997 (“promissory note”), a copy of which was attached to the Consent Order, which called for 60 consecutive monthly installments, beginning on November 1, 1997 and ending October 1, 2002. The Consent Order also provided security in the form of two personal guarantees, an assignment of QBI stock to be held in escrow by QBI in the event of a default under the terms of a pledge and security agreement and a second mortgage (“the mortgage”) on real property rented to QBI as its place of business, but owned by an affiliate of QBI, MRA Associates, LLC (“MRA”). The parties further agreed in ¶ 3 of the Consent Order

that no disparaging statements shall be made by any of the parties and that the terms and conditions of this settlement shall remain confidential, including information relating to QBI provided pursuant to the Promissory Note, Mortgage, Pledge and Security Agreement, and Guaranty Agreement, except as may be necessary to (a) enforce the terms and conditions of this settlement; (b) to comply with reasonable requests of third parties regarding the parties respective businesses and/or (c) as may be required by law.

In exchange, Triarco agreed to dismiss the state court action with prejudice and without costs.

The Consent Order contains no admission of guilt by QBI. QBI claims that its motive for settling the case was to end almost five years of contentious, expensive litigation and to put an end to the difficulty of remaining in business in the face of the continuing derogatory and purportedly false allegations being made by Triarco. Therefore, QBI insisted on the inclusion of ¶ 3 and would not have agreed to the settlement without it.

On July 12, 1999, QBI filed a voluntary petition for relief under chapter 11 of the Bankruptcy Code. As of the petition date, QBI apparently had paid $420,000 to Triarco under the promissory note, because Triarco filed a proof of claim for $780,000, plus costs and interest.

On August 3, 1999, an attorney for the United States’ Trustee convened a meeting of the largest creditors of the debtor to form an official committee of unsecured creditors (the “committee formation meeting”). Rohde, as principal of Triarco, was present at the committee formation meeting. When Rohde was asked by the U.S. Trustee’s attorney to state the basis of Triarco’s claim against QBI, he replied that the basis was “theft” and “stealing”. As a result, John Schortz (“Schortz”), the president of the debtor, who was also present, complained to the U.S. Trustee’s attorney that Rohde’s remarks evinced a malicious attitude toward the debtor and, she apparently agreed that Rohde should not have a seat on the committee. QBI further alleges that Schortz has had subsequent conversations with suppliers and other creditors who were present at the committee formation meeting “who voiced their dismay at what was said by Mr. Rohde and have advised me that the comments were unsettling. There has definitely been a reluctance of the suppliers to continue to do business with the Company [QBI] in Chapter 11.” (¶ 14, Certification of Joseph R. Schortz, President of the debtor, in opposition to defendants’ motion for summary judgment).

On November 3, 1999, plaintiff filed the within complaint. The defendants filed a motion for summary judgment on February 8, 2000. Plaintiff filed opposition and *625 on February 24, 2000, a motion to amend the complaint, to join MRA as co-plaintiff, and to set forth a claim for recovery of preferential payments.

The Defendants’ Position

Defendants argue in support of their motion for summary judgment that the statements made by Rohde were made in the course of a judicial proceeding and thus are absolutely privileged, and furthermore, they are true. Thus there is no action for defamation as a matter of law. Defendants also argue that Rohde’s statements are protected by the “fair report privilege” because they represented a summary of the complaint in the state court action. 1

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
249 B.R. 619, 2000 Bankr. LEXIS 646, 2000 WL 781403, Counsel Stack Legal Research, https://law.counselstack.com/opinion/quality-botanical-ingredients-inc-v-triarco-industries-inc-in-re-njb-2000.